ANIP
NASDAQ · Pharmaceuticals
Ani Pharmaceuticals Inc
$80.39
+0.94 (+1.18%)
Open$80.11
Previous Close$79.45
Day High$81.04
Day Low$79.00
52W High$99.50
52W Low$56.71
Volume—
Avg Volume276.1K
Market Cap1.86B
P/E Ratio23.68
EPS$3.70
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
-54.3% upside
Current
$80.39
$80.39
Target
$36.71
$36.71
$28.36
$36.71 avg
$54.52
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 960.24M | 681.94M | 587.23M |
| Net Income | 85.15M | 54.43M | 76.98M |
| Profit Margin | 8.9% | 8.4% | 13.1% |
| EBITDA | 222.24M | 149.94M | 125.34M |
| Free Cash Flow | — | — | 59.62M |
| Rev Growth | +40.8% | +40.8% | +23.0% |
| Debt/Equity | 1.14 | 1.14 | 0.51 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |